Measles and rubella elimination: communicating the importance of vaccination
The goal of this project is to support EU Member States in their fight against measles and rubella. This report should enable Member States to engage in effective, evidence-based risk communication.
Disease factsheet about rubella
Rubella is a mild febrile rash illness caused by rubella virus. It is transmitted from person to person via droplets (the virus is present in throat secretions). It affects mainly, but not only, children and when pregnant women are infected, it may result in malformation of the foetus. Humans are the only reservoir of infection.
Prevention and control measures for congenital rubella syndrome (CRS)
Congenital rubella syndrome is prevented by ensuring that everyone in the EU is vaccinated against rubella. In particular, women who are planning to get pregnant should be vaccinated as this protects the mother as well as the foetus.
Infographic: Protect unborn babies from rubella
Rubella is a viral infection transmitted from person to person by droplets via coughs and sneezes. In healthy individuals it is usually a mild disease. Up to 50 % of individuals infected with rubella may not show symptoms. However, if a woman gets rubella shortly before getting pregnant or during the first three months of pregnancy, it is very likely to result in miscarriage or congenital anomalies known as congenital rubella syndrome (CRS).
Retrospective surveillance and enhanced case-finding of congenital rubella syndrome cases
The generic protocol presented in this document was developed for ECDC by fellows of the EPIET programme to provide EU/EEA Member States with an adaptable tool to estimate the incidence of congenital rubella syndrome (CRS) cases in their countries.
Surveillance of congenital rubella and rubella infections in pregnancy in EU/EEA countries, 2012: Current status and future perspective to monitor elimination
Giambi, C., Montaño-Remacha, C., Celentano, L.P., Derrough, T.